| NCT Number | NCT06956105 |
| Lead Sponsor | Neurovalens Ltd. |
| Conditions | General Anxiety Disorder |
| Enrollment | 60 participants |
| Start Date | 2025-09-08 |
| Primary Completion | 2026-06-13 (estimated) |
| Study Completion | 2026-06-13 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-01 |